Jubilant Ingrevia Limited Earnings Summary — Q1 FY2027
Jubilant Ingrevia Reports Strong Q1 Growth as Net Profit Surges 41% YoY Amid Revenue Recovery
Quarterly Business Intelligence
AI Quarterly Scorecard™
Computed deterministically from the last 10 reported quarters.
Quarterly Business Momentum
- Revenue has increased for 3 consecutive quarters.
- Revenue of ₹1,300 Cr is 25.3% higher year-on-year.
- Revenue has compounded at 8.8% annualised over the last 10 quarters.
- Revenue is at its highest level in 10 quarters.
- Net profit has reached its highest level in 10 quarters.
- Net profit of ₹106 Cr is 40.9% above the same quarter last year.
- Profit growth is outpacing revenue growth, pointing to positive operating leverage.
- Net profit has compounded at 77.1% annualised across the period.
- Operating margin stands at 15.3% in Q1 FY2027.
- Operating margin expanded by 163 bps year-on-year.
- Over the last two years operating margin has expanded by 462 bps.
- PBT margin is 10.8%.
- Expense growth of 22.9% remained below revenue growth of 25.3%.
- Operating profit of ₹199 Cr is 40.2% higher year-on-year.
- Operating leverage continues to improve.
- 4 of the last 6 measured quarters delivered year-on-year revenue growth.
- Overall quarterly business momentum scores 76/100 (Strong) on the latest 10 quarters.
- Business momentum remains positive heading into the next quarter.
Quarterly Financials
Last 10 Reported Quarters • All figures in ₹ Crore • Margins in %
| Metric | Trend | Latest Q1 FY2027 | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q4 FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | Stable | 1,300 | 1,179 | 1,051 | 1,121 | 1,038 | 1,051 | 1,057 | 1,045 | 1,024 | 1,074 |
| Expenses | Stable | 1,101 | 1,016 | 924 | 985 | 896 | 905 | 918 | 921 | 915 | 983 |
| Operating Profit | Improving | 199 | 163 | 126 | 135 | 142 | 147 | 138 | 124 | 110 | 91 |
| Operating Margin | Improving | 15.3% | 13.8% | 12.0% | 12.1% | 13.7% | 13.9% | 13.1% | 11.9% | 10.7% | 8.5% |
| Other Income | Volatile | 10 | 9 | -4 | 11 | 11 | 8 | 9 | 10 | 10 | 10 |
| Interest | Accelerating | 17 | 12 | 12 | 12 | 13 | 14 | 12 | 15 | 14 | 14 |
| Depreciation | Improving | 51 | 48 | 45 | 41 | 41 | 39 | 40 | 40 | 39 | 36 |
| Profit Before Tax | Improving | 141 | 112 | 65 | 93 | 100 | 102 | 96 | 80 | 66 | 51 |
| Tax | Accelerating | 35 | 25 | 19 | 23 | 25 | 28 | 26 | 21 | 17 | 22 |
| Net Profit | Strong Uptrend | 106 | 86 | 47 | 69 | 75 | 74 | 69 | 59 | 49 | 29 |
| Net Margin | Strong Uptrend | 8.1% | 7.3% | 4.5% | 6.2% | 7.2% | 7.0% | 6.6% | 5.6% | 4.8% | 2.7% |
Key Takeaways
- Revenue from operations grew by 25.3% YoY to ₹1,300 crore, driven by strong performance across key segments.
- Consolidated Net Profit witnessed a robust increase of 40.9% YoY and 22.4% QoQ, reaching ₹105.8 crore for the quarter.
- Operating margins improved significantly to 11.39% compared to 9.76% in the same quarter last year, reflecting better operational efficiency.
- The Chemical Intermediates segment saw a sharp recovery in standalone results, contributing ₹8,452 lakhs to segment profit compared to a loss in the prior quarter.
- The Speciality Chemicals segment remains the primary engine of profitability, generating ₹10,914 lakhs in segment results at the consolidated level.
- Debt-to-equity ratio remains stable at 0.22x, despite continuous investments in capacity expansion.
- Asset utilization is improving, with inventory turnover increasing to 0.64x compared to 0.53x in the same quarter previous year.
Management Guidance
Management remains focused on transitioning from commoditized ingredients to high-value CDMO and nutrition solutions. Strategic investments in Speciality Chemicals and Innovative Solutions are intended to reduce cyclical exposure and improve long-term margin profiles.
Sentiment Shift
Improving
A clear reversal in the downward margin trend seen in previous years, supported by strong volume growth and segment-level recovery in Chemical Intermediates.
Outlook
The outlook is positive as the company shows signs of margin stabilization above 11%. Continued vertical integration and capacity additions in Specialty Chemicals are expected to drive top-line growth and earnings quality throughout FY2027.
From the Annual Report (Key Quotes)
“Profit before taxation for the quarter stood at ₹14,086 lakhs, compared to ₹9,977 lakhs in Q1 FY2026.”
“Revenue from operations for the quarter stood at ₹1,30,027 lakhs against ₹1,03,787 lakhs in the base quarter.”
“The Group continues to monitor developments pertaining to the Labour Codes and would provide appropriate accounting impact on the basis of such developments.”
Official Quarterly Documents
Ask AI about this quarter
This summary is AI-generated from Jubilant Ingrevia Limited's latest quarterly filing and earnings call. For informational purposes only — not investment advice.